TABLE 2.
Compartmental pharmacokinetic parameters of liposomal nystatin in plasma after multiple dosing over 14 daysa
Drug dose (mg/kg · day) | Cmaxb (μg/ml) | Cmin (μg/ml) | AUC0–24b (μg · h/ml) | VD (liters/kg) | VDc (liters/kg) | VDp (liters/kg) | CLtc (liters/kg · h) | CLd (liters/kg · h) | t1/2α (h) | t1/2βd (h) |
---|---|---|---|---|---|---|---|---|---|---|
2 | 12.86 ± 1.34 | 0.00 ± 0.00 | 11.15 ± 1.23 | 0.249 ± 0.039 | 0.123 ± 0.011 | 0.126 ± 0.030 | 0.168 ± 0.019 | 0.272 ± 0.077 | 0.141 ± 0.013 | 1.200 ± 0.054 |
4 | 24.65 ± 2.10 | 0.00 ± 0.00 | 32.00 ± 2.25 | 0.230 ± 0.024 | 0.137 ± 0.011 | 0.092 ± 0.012 | 0.118 ± 0.008 | 0.205 ± 0.043 | 0.182 ± 0.045 | 1.520 ± 0.189 |
6 | 50.40 ± 3.79 | 0.00 ± 0.00 | 88.20 ± 14.06 | 0.159 ± 0.017 | 0.101 ± 0.008 | 0.057 ± 0.008 | 0.071 ± 0.013 | 0.186 ± 0.004 | 0.128 ± 0.013 | 1.700 ± 0.097 |
All values are expressed as means ± standard errors of the means. Cmin, plasma concentration at the end of the dosing interval.
P < 0.001 by ANOVA.
P = 0.005 by ANOVA.
P = 0.03 by ANOVA.